Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRINOX vs Gemcitabine in Metastatic Pancreatic Cancer
NCT00112658Phase 3Completed
- Sponsor
- Unicancer
- Start
- Nov 2004
- Primary completion
- Jun 2010
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, irinotecan, fluorouracil, folinic acid, sponsored by Unicancer. Started Nov 2004; status: completed.
02
Drugs
oxaliplatinirinotecanfluorouracilfolinic acid
Beyond the preview
Go deeper on NCT00112658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112658.